FDA Inspection 1226957 — Revlon Group Holdings, LLC
The FDA completed an inspection of Revlon Group Holdings, LLC on January 12, 2024 in Oxford, NC. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 3 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 12, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Oxford, NC (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 1213 | 21 CFR 211.67(a) | Cleaning / Sanitizing / Maintenance |
| 1636 | 21 CFR 211.130(e) | Packaging line inspection before use |
| 3603 | 21 CFR 211.160(b) | Scientifically sound laboratory controls |